ZIOPHARM Oncology (ZIOP)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in ZIOPHARM Oncology (ZIOP) since 2017: 0 buys and 1 sale. The most recent was disclosed on Nov 14, 2017.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $250K–$500K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at ZIOP
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded ZIOP
- Sen. Mark R. Warner (D-VA)0 buys · 1 sale01Nov 14, 2017
All trades
- Nov 14, 2017$250K–$500K
Sen. Mark R. Warner (D-VA)
Sold (full) ZIOPHARM Oncology ZIOP
$250K–$500K · Traded Oct 18, 2017 · disclosed Nov 14, 2017
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.